In contrast to these reports, which highlight a positive role of mTOR in senescence induced by CDK4/6 inhibition, a significant inhibition of mTORC1 signaling was observed in melanoma and glioma cells after treatment with the CDK4/6 inhibitor palbociclib [16,18,128]. Here, CDK4 is linked to central nervous system cancer.